Endothelin-A Receptor Antagonism Reduces Blood Pressure and Increases Renal Blood Flow in Hypertensive Patients With Chronic Renal Failure

Jane Goddard, Neil R. Johnston, Malcolm F. Hand, +4

Circulation

Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease

Neeraj Dhaun, I. MacIntyre, D.J. Kerr, +5

Hypertension

Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease

Neeraj Dhaun, I. MacIntyre, Vanessa Melville, +4

Hypertension

Acute renal dysfunction following hip fracture

Simon Bennet, Olivia M.B. Berry, Jane Goddard, +1

Injury

Skeletal TraumaHemodialysisHip FractureMedicineKidney Failure +6

Systemic ETA receptor antagonism with BQ‐123 blocks ET‐1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men

James Spratt, Jane Goddard, Neil R. Patel, +3

British Journal of Pharmacology

Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease

Ana Reis, Alisa Rudnitskaya, Pajaree Chariyavilaskul, +6

Journal of Lipid Research

Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis

Neeraj Dhaun, Pajaree Lilitkarntakul, I. MacIntyre, +5

American Journal of Physiology-Renal Physiology

Glomerular DiseaseRenal PathologyImmunologyRenal InflammationInflammation +18

Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity

Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, +7

Atherosclerosis

HypertensionUrologyRenal DiseaseRenal FunctionCardiovascular Disease +9

Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes

Boris Betz, Sara Jenks, Andrew D. Cronshaw, +11

Kidney International

UrologyRenal DiseaseRenal FunctionMedicineKidney Failure +9

Endothelin A Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition Are Synergistic via an Endothelin B Receptor–Mediated and Nitric Oxide–Dependent Mechanism

Jane Goddard, Corine Eckhart, Neil R. Johnston, +3

Journal of the American Society of Nephrology